Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II-Reference-Cited by-同舟云学术

Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II

Published:2018-03 Issue:3 Volume:36 Page:462-471
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Rossi Gian Paolo,Seccia Teresa M.,Barton Matthias,Danser A.H. Jan,de Leeuw Peter W.,Dhaun Neeraj,Rizzoni Damiano,Rossignol Patrick,Ruilope Luis-Miguel,van den Meiracker Anton H.,Ito Sadayoshi,Hasebe Naoyuki,Webb David J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference129 articles.

1. Cellular mediators of renal vascular dysfunction in hypertension;Ponnuchamy;Am J Physiol Regul Integr Comp Physiol,2009

2. Endothelial dysfunction and mild renal insufficiency in essential hypertension;Perticone;Circulation,2004

3. Renal Parenchymal Hypertension: current concepts of pathogenesis and management;Preston;Arch Intern Med,1996

4. Endothelin and endothelin antagonists in chronic kidney disease;Kohan;Kidney Int,2014

5. Glomerular hyperfiltration and renal disease progression in type 2 diabetes;Ruggenenti;Diabetes Care,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project);JMIR Research Protocols;2024-05-29

2. Kidney transplantation in recipient with hyperhomocysteinemia: a case report;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2024-04-19

3. Identification and characterization of two immune-related subtypes in human chronic kidney disease;Transplant Immunology;2024-02

4. Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project) (Preprint);2024-01-04

5. Endothelin System in Hypertension and Chronic Kidney Disease;Hypertension;2023-12-07